Pfizer/BioNTech Combo Vaccine Shows Partial Flu Efficacy
Setback Could Benefit Moderna
The companies said their combination mRNA vaccine showed protection against SARS-CoV-2 and influenza A, but not influenza B.
The companies said their combination mRNA vaccine showed protection against SARS-CoV-2 and influenza A, but not influenza B.